Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid
AssigneeAventis Pharma Deutschland GmbH
InventorsHeinz-Werner Kleemann, Peter Below
Life of this patent
Estimating the term…
Abstract
Dihydrothiaphenanthrenecarbonylguanidine compound of formula I These compounds are potentially suitable as antiarrythmic medicaments with a cardioprotective component for prophylaxis of an infarction and treatment of infarction, and for treatment of angina pectoris. They may also inhibit in a preventive manner the pathophysiological processes involved in the development of ischemia-induced damage, especially in the initiation of ischemia-induced cardiac arrhythmias.
Claims16
A dihydrothiaphenanthrenecarbonylguanidine compound of formula I or a pharmaceutically suitable salt of said compound:
- wherein:
- R1 and R3 are independently selected from the group consisting of hydrogen, —(C1-C4)-alkyl, —(C1-C4)-alkoxy, —F, —Cl, —Br, —I, —CN, —NR10R11, —Op—(CH2)n—(CF2)x—CF3, and —(SOm)p—(CH2)n—(CF2)x—CF3, wherein:
- R10 and R11 are independently selected from the group consisting of hydrogen, —(C1-C4)-alkyl and —(CH2)n—(CF2)x—CF3,
- m=0, 1 or 2,
- n=0, 1, 2, 3, 4, 5 or 6,
- x=0 or 1, and
- p=0 or 1;
- R2 is selected from the group consisting of hydrogen, —F, —Cl, —Br, —I, —CN, —(C1-C4)-alkyl, methoxy, and —(C3-C8)-cycloalkyl;
- R4 and R5 are independently selected from the group consisting of hydrogen and —(C1-C4) alkyl;
- R6, R7, R8 and R9 are independently selected from the group consisting of hydrogen, —(C1-C4)-alkyl;
- —(C1-C4)-alkoxy, —F, —Cl, —Br, —I, —CN, —NR12R13, —Oq—(CH2)r—(CF2)s—CF3 and —(SOw)t—(CH2)u—(CF2)v—CF3, wherein:
- R12 and R13 are independently selected from the group consisting of hydrogen and —(C1-C4)-alkyl,
- w=0, 1 or 2,
- r=0, 1, 2, 3, 4, 5, or 6,
- u=0, 1, 2, 3, 4, 5, or 6,
- q=0 or 1
- s=0 or 1
- t=0 or 1, and
- v=0 or 1;
- or
- R6 and R7, together with ring 1, form a naphthalene system and R8 and R9 remain as defined above;
- or
- R7 and R8, together with ring 1, form a naphthalene system and R6 and R9 remain as defined above;
- or
- R8 and R9, together with ring 1, form a naphthalene system and R6 and R7 remain as defined above;
- and
- A is selected from the group consisting of —S—, —SO— and —SO2—.
Dependencies are inferred from the claim text.